Open Medicine最新文献

筛选
英文 中文
Antiangiogenic potential of Elaeagnus umbellata extracts and molecular docking study by targeting VEGFR-2 pathway. 黑叶参提取物抗血管生成潜能及靶向VEGFR-2途径的分子对接研究
IF 1.7 4区 医学
Open Medicine Pub Date : 2025-01-16 eCollection Date: 2025-01-01 DOI: 10.1515/med-2024-1083
Nausheen Nazir, Arbaz Waqar, Amir Zaib Khan, Ayaz Ali Khan, Tariq Aziz, Abdullah F Alasmari
{"title":"Antiangiogenic potential of <i>Elaeagnus umbellata</i> extracts and molecular docking study by targeting VEGFR-2 pathway.","authors":"Nausheen Nazir, Arbaz Waqar, Amir Zaib Khan, Ayaz Ali Khan, Tariq Aziz, Abdullah F Alasmari","doi":"10.1515/med-2024-1083","DOIUrl":"10.1515/med-2024-1083","url":null,"abstract":"<p><strong>Background: </strong>Anti-angiogenesis or inhibition of blood vessel formation is the best way to prevent the growth and metastasis of tumors. Natural sources like plants are currently being explored for its antiangiogenic activity as they are factories of various phytochemicals. The goal of the current study is to investigate the antiangiogenic potential of <i>Elaeagnus umbellata</i> (<i>E. umbellata</i>) by using chorioallantoic membrane (CAM) assay and molecular docking.</p><p><strong>Methods: </strong>Based on our previous research, the antiangiogenic activity was carried out using active fractions including crude methanol (Eu-Met), ethyl acetate (Eu-EtAc), and chloroform (Eu-Chf) extracts using CAM assay. Furthermore, to understand the binding mechanism of identified compounds, molecular docking was performed against vascular endothelial growth factor receptor 2 (VEGFR-2) using AutoDock vina as docking software. VEGFR-2 is overexpressed in pathological angiogenesis.</p><p><strong>Results: </strong>In CAM assay, Eu-Met, Eu-EtAc, and Eu-Chf extracts showed antiangiogenic activities but notable antiangiogenic activities were exhibited by Eu-Chf with IC<sub>50</sub> value of 65.02 μg/mL. In molecular docking, five compounds, catechin, catechin hydrate, morin, quercetin, and rutin, reported in the extract and active fractions (Eu-Met, Eu-EtAc, and Eu-Chf) of <i>E. umbellata</i> showed strong interactions with VEGFR-2 with binding affinities of -9.4, -9.3, -9.9, -10.2, and -9.4 kcal/mol.</p><p><strong>Conclusion: </strong>Based on our results, we can claim that <i>E. umbellata</i> possess antiangiogenic activity which needs to be explored further.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20241083"},"PeriodicalIF":1.7,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742088/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143009413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CMSP exerts anti-tumor effects on small cell lung cancer cells by inducing mitochondrial dysfunction and ferroptosis. CMSP通过诱导线粒体功能障碍和铁下垂对小细胞肺癌细胞有抗肿瘤作用。
IF 1.7 4区 医学
Open Medicine Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.1515/med-2024-1100
Xi Yan, Yinghao Niu, Yaojie Wang, Sisi Wei, Lina Han, Zhongyu Guo, Lianmei Zhao, Feng Gao
{"title":"CMSP exerts anti-tumor effects on small cell lung cancer cells by inducing mitochondrial dysfunction and ferroptosis.","authors":"Xi Yan, Yinghao Niu, Yaojie Wang, Sisi Wei, Lina Han, Zhongyu Guo, Lianmei Zhao, Feng Gao","doi":"10.1515/med-2024-1100","DOIUrl":"https://doi.org/10.1515/med-2024-1100","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to investigate the role and mechanism of <i>p</i>-hydroxyl cinnamaldehyde (CMSP) in triggering ferroptosis of small cell lung cancer (SCLC) cells.</p><p><strong>Methods: </strong>The impact of CMSP on ferroptosis in H1688 and SW1271 cells was assessed through cell experiments and biological information analysis. Moreover, the expression of heme oxygenase 1 (HMOX1) in SCLC tissue was examined.</p><p><strong>Results: </strong>Following CMSP treatment, a concentration-dependent increase in cell death was observed, and differentially expressed genes were found to be associated with ferroptosis. CMSP notably facilitated ferroptosis events, such as elevated levels of reactive oxygen species (ROS), Fe<sup>2+</sup>, malondialdehyde (MDA), transferrin receptor 1 (TFR1), divalent metal transporter 1 (DMT1), and decreased levels of glutathione (GSH), solute carrier family 7 member 11 (SLC7A11), and glutathione peroxidase 4 (GPX4). Furthermore, CMSP promoted mitochondrial dysfunction, manifested as reduced mitochondrial volume, increased membrane density, elevated mitochondrial ROS, and decreased mitochondrial membrane potential. Consistently, the mitochondrial-targeted antioxidant Mito-TEMPO reversed CMSP-induced ferroptosis. Expression of the HMOX1 gene was markedly increased under CMSP treatment, while lower expression was observed in cancer tissue compared to adjacent tissue.</p><p><strong>Conclusion: </strong>CMSP triggers mitochondrial dysfunction via HMOX1 activation, leading to ferroptosis in SCLC cells, underscoring its potential as a therapeutic agent for SCLC.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20241100"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143009414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia. 血浆sB7-H3和YKL-40对小儿难治性肺炎支原体肺炎的预测价值。
IF 1.7 4区 医学
Open Medicine Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.1515/med-2024-1114
QiuMin Zhao, ShiYan Ji, HaiPing Jiang, DongMing Lu, LiFen Qian, JingWen Zhang, Yue Cui, Wei Lin, HaoYing Ge, Meng Gu
{"title":"Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia.","authors":"QiuMin Zhao, ShiYan Ji, HaiPing Jiang, DongMing Lu, LiFen Qian, JingWen Zhang, Yue Cui, Wei Lin, HaoYing Ge, Meng Gu","doi":"10.1515/med-2024-1114","DOIUrl":"https://doi.org/10.1515/med-2024-1114","url":null,"abstract":"<p><strong>Objective: </strong>This study investigated the clinical significance of plasma sB7-H3 and YKL-40 levels in children with refractory Mycoplasma pneumoniae pneumonia (RMPP).</p><p><strong>Methods: </strong>A total of 182 RMPP patients (103 general Mycoplasma pneumoniae patients and 79 RMPP patients) were included. sB7-H3, YKL-40, and other inflammatory factors were measured. Independent factors associated with the early diagnosis of RMPP were determined. The value of each independent risk factor in predicting RMPP was evaluated.</p><p><strong>Results: </strong>The RMPP group reported significantly longer hospital stays and total fever durations. Levels of C-reactive protein, D-dimer, IL-13, IL-6/-10, sB7-H3, and YKL-40 were higher in the RMPP group. sB7-H3 was positively correlated with IL-13, IL-6, and IL-4, whereas YKL-40 was positively correlated with all of the above indicators (IL-5 was also included). sB7-H3 and YKL-40 were independent risk factors for RMPP. The critical values for sB7-H3 and YKL-40 were 3.525 and 313.3 ng/mL, respectively. sB7-H3 and YKL-40 had areas under the curve of 0.734 and 0.859, respectively. YKL-40 had high sensitivity and specificity of 88.61 and 87.38%, respectively. Both indicators had predictive value, YKL-40 had the highest predictive ability for RMPP.</p><p><strong>Conclusion: </strong>Detection of sB7-H3 and YKL-40 levels in the plasma may be useful in diagnosing RMPP early in the disease process.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20241114"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143009422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of headspace gas chromatography with a flame ionization detector method for the determination of ethanol in the vitreous humor. 用火焰电离检测器顶空气相色谱法测定玻璃体中乙醇的方法的建立和验证。
IF 1.7 4区 医学
Open Medicine Pub Date : 2025-01-15 eCollection Date: 2025-01-01 DOI: 10.1515/med-2024-1123
Filip Mihajlović, Ivana Andrić, Živana Slović, Maja Vujović, Kristina Piskulić, Snežana Đorđević
{"title":"Development and validation of headspace gas chromatography with a flame ionization detector method for the determination of ethanol in the vitreous humor.","authors":"Filip Mihajlović, Ivana Andrić, Živana Slović, Maja Vujović, Kristina Piskulić, Snežana Đorđević","doi":"10.1515/med-2024-1123","DOIUrl":"10.1515/med-2024-1123","url":null,"abstract":"<p><strong>Introduction: </strong>Qualitative and quantitative testing of ethanol in <i>post-mortem</i> samples is an important analytical procedure that provides accurate, precise, and reliable results. Given the complexity of the issue, obtaining a realistic picture of lifelong alcoholemia requires supporting blood ethanol findings with analyses of alternative samples, primarily vitreous humor (VH).</p><p><strong>Objective: </strong>The objective of this study was to develop and validate a headspace gas chromatography with flame ionization detection (HS/GC-FID) method for determining ethanol concentration in VH.</p><p><strong>Materials and methods: </strong>Conditions for the HS/GC-FID method were established and the method was validated according to the guidelines of the European Medicines Agency. Validation parameters such as precision, accuracy, specificity, sensitivity, and linearity over a wide concentration range were evaluated through statistical analysis.</p><p><strong>Results: </strong>The method demonstrated precision, accuracy, specificity, and sensitivity. Additionally, it proved to be linear across a wide concentration range and relatively fast, making it suitable for rapid and routine determination of ethanol concentration in VH, particularly for forensic applications.</p><p><strong>Conclusion: </strong>Results from validation and application of the method to VH samples indicate that ethanol concentration in VH can be reliably determined using the presented HS/GC-FID method, making it a valuable tool in forensic investigations.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20241123"},"PeriodicalIF":1.7,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143009416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knockdown of CCNB1 alleviates high glucose-triggered trophoblast dysfunction during gestational diabetes via Wnt/β-catenin signaling pathway. CCNB1的下调通过Wnt/β-catenin信号通路缓解妊娠期糖尿病中高糖引发的滋养细胞功能障碍。
IF 1.7 4区 医学
Open Medicine Pub Date : 2025-01-13 eCollection Date: 2025-01-01 DOI: 10.1515/med-2024-1119
Biru Xiao, Wenmiao Zhang, Nini Ji, Qiuyue Chen
{"title":"Knockdown of CCNB1 alleviates high glucose-triggered trophoblast dysfunction during gestational diabetes via Wnt/β-catenin signaling pathway.","authors":"Biru Xiao, Wenmiao Zhang, Nini Ji, Qiuyue Chen","doi":"10.1515/med-2024-1119","DOIUrl":"10.1515/med-2024-1119","url":null,"abstract":"<p><p>Gestational diabetes mellitus (GDM), defined as glucose intolerance occurring or first detected during pregnancy, affects approximately 8% of pregnancies worldwide. The dysfunction of trophoblasts in pregnancies complicated by GDM is associated with changes in trophoblast cell functions, resulting in compromised proliferation and regulation of the cell cycle. Cyclin B1 (CCNB1), a pivotal controller of the start of mitosis, is crucial in these mechanisms. Nevertheless, the precise function of CCNB1 in trophoblast dysfunction related to GDM has not been extensively investigated. The aim of this study was to investigate CCNB1's role in high glucose (HG)-triggered trophoblast. Herein, we revealed that in HG-stimulated HTR8/SVneo cells, CCNB1 is highly expressed. Knockdown of CCNB1 significantly promotes the growth of HG-stimulated HTR8/SVneo cells and suppresses inflammation (<i>p</i> < 0.05). Additionally, reducing CCNB1 expression significantly improves glucose uptake and inhibits the Wnt/β-catenin pathway in HG-stimulated HTR8/SVneo cells (<i>p</i> < 0.05). In conclusion, our study demonstrated that the deletion of CCNB1 can alleviate trophoblast dysfunction induced by HG in GDM through the Wnt/β-catenin pathway. This suggests that CCNB1 may be a potential target for managing GDM. Although our results underscore the potential therapeutic benefits of reducing CCNB1 in mitigating trophoblast dysfunction, it is important to note that the study is limited by its reliance on a single cell line and the absence of <i>in vivo</i> validation.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20241119"},"PeriodicalIF":1.7,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143009420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for severe adverse drug reactions in hospitalized patients. 住院患者严重药物不良反应的危险因素。
IF 1.7 4区 医学
Open Medicine Pub Date : 2025-01-13 eCollection Date: 2025-01-01 DOI: 10.1515/med-2024-1122
Nemanja Z Petrović, Ana V Pejčić, Miloš N Milosavljević, Slobodan M Janković
{"title":"Risk factors for severe adverse drug reactions in hospitalized patients.","authors":"Nemanja Z Petrović, Ana V Pejčić, Miloš N Milosavljević, Slobodan M Janković","doi":"10.1515/med-2024-1122","DOIUrl":"10.1515/med-2024-1122","url":null,"abstract":"<p><strong>Background: </strong>Severe adverse drug reactions (sADRs) are becoming increasingly common nowadays. The incidence of sADRs is approaching 6.7%, and the incidence of fatal adverse reactions is 0.32% in hospitalized patients. Of these, 48.5% are, at least potentially, preventable.</p><p><strong>Aims: </strong>This study's objective was to determine factors associated with the occurrence and preventability of sADRs occurring at the tertiary level.</p><p><strong>Methods: </strong>A case-control retrospective-prospective clinical observational study design was used for the study. The research cohort included patients hospitalized at the University Clinical Center (UCC) in Kragujevac, Serbia, from January 1, 2019 to January 1, 2024. The research comprised 147 individuals who were admitted to the UCC in Kragujevac. There were 49 patients with sADRs and 98 controls.</p><p><strong>Results: </strong>Significant factors associated with sADRs in our study were a total number of consultations (ORadjusted = 5.60), Charlson comorbidity index (ORadjusted = 0.30), C-reactive protein (ORadjusted = 1.07), prescribed antihistamines (ORadjusted = 14.37), and antihypertensives (ORadjusted = 0.15).</p><p><strong>Conclusion: </strong>We have identified the factors that are associated with sADRs should be kept in mind while working with patients at the tertiary level. Early detection of those factors may help with early notification of sADRs and their prevention.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20241122"},"PeriodicalIF":1.7,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer. 揭示卵巢癌铂化疗耐药的新生物标志物。
IF 1.7 4区 医学
Open Medicine Pub Date : 2025-01-13 eCollection Date: 2025-01-01 DOI: 10.1515/med-2024-1084
Caixia Wang, Changsheng Peng, Chuan Xie
{"title":"Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer.","authors":"Caixia Wang, Changsheng Peng, Chuan Xie","doi":"10.1515/med-2024-1084","DOIUrl":"10.1515/med-2024-1084","url":null,"abstract":"<p><p>Primary chemoresistance to platinum-based treatment is observed in approximately 33% of individuals diagnosed with ovarian cancer; however, conventional clinical markers exhibit limited predictive value for chemoresistance. This study aimed to discover new genetic markers that can predict primary resistance to platinum-based chemotherapy. Through the analysis of three GEO datasets (GSE114206, GSE51373, and GSE63885) utilizing bioinformatics methodologies, we identified two specific genes, MFAP4 and EFEMP1. The findings revealed that the areas under the receiver operating characteristic curves for MFAP4 and EFEMP1 were 0.716 and 0.657 in the training cohort, and 0.629 and 0.746 in the testing cohort, respectively. In all cases or in cases treated with platin, high expression of MFAP4 and EFEMP1 was linked to shortened overall survival and progression-free survival. MFAP4 and EFEMP1 were positively correlated with epithelial-mesenchymal transition, TGF-β signaling, KRAS signaling, and so on. The high expression groups of MFAP4 and EFEMP1 exhibited elevated stromal, immune, and ESTIMATE scores. Finally, we constructed a regulatory network involving lncRNA-miRNA-mRNA interactions. In summary, MFAP4 and EFEMP1 have the potential to serve as predictive indicators for both response to platinum-based chemotherapy and survival rates, and might be regarded as innovative biomarkers and therapeutic targets for OC patients.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20241084"},"PeriodicalIF":1.7,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the effect of ALA-PDT on macrophages in footpad model of mice infected with Fonsecaea monophora based on single-cell sequencing. 基于单细胞测序分析ALA-PDT对单核真菌感染小鼠足垫模型巨噬细胞的影响。
IF 1.7 4区 医学
Open Medicine Pub Date : 2025-01-13 eCollection Date: 2025-01-01 DOI: 10.1515/med-2024-1132
Wenyi Chen, Xuelin Wu, Muhammad Danish Yaqoob, Kangxing Liu, Yanqing Hu, Xiuling Ke, Yongxuan Hu
{"title":"Analysis of the effect of ALA-PDT on macrophages in footpad model of mice infected with <i>Fonsecaea monophora</i> based on single-cell sequencing.","authors":"Wenyi Chen, Xuelin Wu, Muhammad Danish Yaqoob, Kangxing Liu, Yanqing Hu, Xiuling Ke, Yongxuan Hu","doi":"10.1515/med-2024-1132","DOIUrl":"10.1515/med-2024-1132","url":null,"abstract":"<p><p>Chromoblastomycosis (CBM) is a chronic neglected fungal disease that causes serious damage to the physical and mental health of patients. 5-Aminolevulinic acid photodynamic therapy (ALA-PDT) has garnered significant attention in the recent era for the treatment of CBM and has exhibited promising effects in several clinical case reports. We established a mice footpad infection model with <i>Fonsecaea monophora</i> and analyzed the impact of PDT treatment on the immune response of macrophages using single-cell sequencing. The results showed that infection of the mouse footpad skin with <i>F. monophora</i> results in an increase in inflammatory cells, primarily mononuclear-macrophages, with the activation of complement and enhancement of cell chemotaxis, leading to upregulation of anti-infection-related pathways. After ALA-PDT treatment, the number of inflammatory cells decreased, while macrophages upregulated the expression of antigen-recognition-related genes, enhancing phagocytosis and autophagy-related biological functions.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20241132"},"PeriodicalIF":1.7,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143009412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes-related cognitive impairment: Mechanisms, symptoms, and treatments. 糖尿病相关认知障碍:机制、症状和治疗
IF 1.7 4区 医学
Open Medicine Pub Date : 2025-01-13 eCollection Date: 2025-01-01 DOI: 10.1515/med-2024-1091
Xueting Yu, Huimei He, Jie Wen, Xiuyuan Xu, Zhaojuan Ruan, Rui Hu, Fang Wang, Haibing Ju
{"title":"Diabetes-related cognitive impairment: Mechanisms, symptoms, and treatments.","authors":"Xueting Yu, Huimei He, Jie Wen, Xiuyuan Xu, Zhaojuan Ruan, Rui Hu, Fang Wang, Haibing Ju","doi":"10.1515/med-2024-1091","DOIUrl":"10.1515/med-2024-1091","url":null,"abstract":"<p><strong>Background: </strong>Diabetes-related cognitive impairment is increasingly recognized as a significant complication, profoundly impacting patients' quality of life. This review aims to examine the pathophysiological mechanisms, clinical manifestations, risk factors, assessment and diagnosis, management strategies, and future research directions of cognitive impairment in diabetes.</p><p><strong>Methodology: </strong>A comprehensive literature search was conducted using PubMed, Medline, and other medical databases to identify, review, and evaluate published articles on cognitive impairment in diabetes. The search focused on studies examining pathophysiology, clinical presentations, risk factors, diagnostic approaches, and management strategies.</p><p><strong>Results: </strong>The review of current literature revealed that chronic hyperglycemia, insulin resistance, and vascular factors are major contributing factors to cognitive deficits in diabetes. Clinical manifestations include impairments in attention, memory, executive function, visuospatial abilities, and language. Risk factors encompass disease duration, glycemic control, presence of complications, age, education level, and comorbidities. Assessment tools include cognitive screening instruments, neuropsychological testing, and neuroimaging techniques. Management strategies involve glycemic control optimization, lifestyle modifications, cognitive training, and pharmacological interventions.</p><p><strong>Conclusion: </strong>This review highlights the significant prevalence and impact of cognitive impairment in diabetes, resulting from complex metabolic and vascular disturbances. Early detection and multifaceted interventions are crucial for preserving cognitive function and improving patient outcomes. Future research should focus on neuroprotective strategies, biomarker identification, and personalized approaches. Collaborative efforts between clinicians and researchers are essential to effectively address this growing healthcare challenge and enhance the quality of life for individuals with diabetes-related cognitive impairment.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20241091"},"PeriodicalIF":1.7,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143009418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of diabetes on long-term survival in elderly liver cancer patients: A retrospective study. 糖尿病对老年肝癌患者长期生存影响的回顾性研究
IF 1.7 4区 医学
Open Medicine Pub Date : 2025-01-10 eCollection Date: 2025-01-01 DOI: 10.1515/med-2024-1096
Dan Chen, Xiaoxiao Gao, Yaqing Wang
{"title":"Impact of diabetes on long-term survival in elderly liver cancer patients: A retrospective study.","authors":"Dan Chen, Xiaoxiao Gao, Yaqing Wang","doi":"10.1515/med-2024-1096","DOIUrl":"10.1515/med-2024-1096","url":null,"abstract":"<p><strong>Background and aim: </strong>Liver cancer is a prevalent and life-threatening condition, particularly among elderly individuals. The association between diabetes, a chronic metabolic disorder, and the onset and advancement of liver cancer has been widely acknowledged. However, the effect of diabetes on the survival of older patients with liver cancer has been a topic of debate. In light of this, we undertook a retrospective study to assess the impact of diabetes on the overall survival (OS) of elderly individuals diagnosed with liver cancer.</p><p><strong>Methods: </strong>In this retrospective analysis, we examined clinical data from liver cancer patients aged 80 years or older who underwent diagnosis and treatment at a solitary medical center from January 2010 to December 2019. Comprehensive records encompassing baseline information, treatment protocols, diabetes history, and mortality during follow-up were meticulously documented. Employing the Kaplan-Meier method and the Cox proportional hazards model, we sought to assess the influence of diabetes on both the OS and recurrence-free survival (RFS) in elderly individuals diagnosed with liver cancer.</p><p><strong>Results: </strong>This study comprised 244 elderly liver cancer patients, with 68 individuals reporting a history of diabetes. In the unadjusted Kaplan-Meier survival analysis, the diabetes group exhibited a lower OS compared to the non-diabetes group. Utilizing a multivariate Cox proportional hazards model, diabetes emerged as a prognostic factor influencing OS (hazard ratio, HR = 1.782 [1.163-2.743], <i>P</i> = 0.043). Regarding RFS, unadjusted Kaplan-Meier analysis revealed a diminished RFS in the diabetes group compared to the non-diabetes group. In the multivariate Cox proportional hazards model, diabetes remained a significant prognostic factor impacting RFS (HR = 1.742 [1.083-1.546], <i>P</i> = 0.041).</p><p><strong>Conclusion: </strong>Our study indicates a significant impact of diabetes on both OS and RFS among elderly liver cancer patients. These insights may contribute to more precise guidance and recommendations for the treatment of this specific demographic, offering valuable information for healthcare practitioners working with elderly individuals diagnosed with liver cancer.</p>","PeriodicalId":19715,"journal":{"name":"Open Medicine","volume":"20 1","pages":"20241096"},"PeriodicalIF":1.7,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143009419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信